FI103043B1 - Förfarande för framställning av nya terapeutiskt användbara 8-vinyl- och 8-etynylkinolonkarboxylsyraderivat och mellanprodukter vilka är användbara vid förfarandet - Google Patents
Förfarande för framställning av nya terapeutiskt användbara 8-vinyl- och 8-etynylkinolonkarboxylsyraderivat och mellanprodukter vilka är användbara vid förfarandetInfo
- Publication number
- FI103043B1 FI103043B1 FI923268A FI923268A FI103043B1 FI 103043 B1 FI103043 B1 FI 103043B1 FI 923268 A FI923268 A FI 923268A FI 923268 A FI923268 A FI 923268A FI 103043 B1 FI103043 B1 FI 103043B1
- Authority
- FI
- Finland
- Prior art keywords
- vinyl
- preparation
- useful
- ethynylquinolone
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Paints Or Removers (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI970312A FI970312A (sv) | 1991-07-19 | 1997-01-24 | 8-halogenkinolinkarboxylsyraderivat |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4123918A DE4123918A1 (de) | 1991-07-19 | 1991-07-19 | 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren |
| DE4123918 | 1991-07-19 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI923268A0 FI923268A0 (fi) | 1992-07-16 |
| FI923268A FI923268A (fi) | 1993-01-20 |
| FI103043B1 true FI103043B1 (sv) | 1999-04-15 |
| FI103043B FI103043B (sv) | 1999-04-15 |
Family
ID=6436512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI923268A FI103043B (sv) | 1991-07-19 | 1992-07-16 | Förfarande för framställning av nya terapeutiskt användbara 8-vinyl- o ch 8-etynylkinolonkarboxylsyraderivat och mellanprodukter vilka är anv ändbara vid förfarandet |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0523512B1 (sv) |
| JP (1) | JP3174405B2 (sv) |
| KR (1) | KR100240608B1 (sv) |
| AT (1) | ATE147733T1 (sv) |
| AU (1) | AU658901B2 (sv) |
| CA (1) | CA2073993A1 (sv) |
| CZ (1) | CZ282037B6 (sv) |
| DE (2) | DE4123918A1 (sv) |
| DK (1) | DK0523512T3 (sv) |
| ES (1) | ES2097835T3 (sv) |
| FI (1) | FI103043B (sv) |
| GR (1) | GR3022305T3 (sv) |
| HU (1) | HU219910B (sv) |
| IE (1) | IE80557B1 (sv) |
| IL (1) | IL102520A (sv) |
| MX (1) | MX9204110A (sv) |
| NO (1) | NO302886B1 (sv) |
| PL (1) | PL171910B1 (sv) |
| RU (1) | RU2077533C1 (sv) |
| SK (1) | SK279221B6 (sv) |
| TW (1) | TW201309B (sv) |
| ZA (1) | ZA925351B (sv) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4121214A1 (de) * | 1991-06-27 | 1993-01-14 | Bayer Ag | 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate |
| DE4230804A1 (de) * | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
| DE4303657A1 (de) * | 1993-02-09 | 1994-08-11 | Bayer Ag | Neue Chinolon- und Naphthyridoncarbonsäurederivate |
| KR950018003A (ko) * | 1993-12-09 | 1995-07-22 | 스미스클라인 비참 피엘씨 | 신규한 퀴놀론 유도체 및 그의 제조 방법 |
| DE4418510A1 (de) * | 1994-05-27 | 1995-11-30 | Bayer Ag | 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate |
| DE4425659A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Neue N1-diverse 6-Fluor-8-difluormethoxy substituierte Chinoloncarbonsäuren |
| DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| ATE269320T1 (de) * | 1996-04-19 | 2004-07-15 | Wakunaga Pharma Co Ltd | Neue pyridoncarbonsäure-derivate oder salze dieser derivate und antibakterielle mittel, die diese als aktiven wirkstoff enthalten |
| AU1040597A (en) * | 1996-12-04 | 1998-06-29 | Daiichi Pharmaceutical Co., Ltd. | Substituted aminomethylpyrrolidine derivatives |
| HUP0100051A3 (en) | 1997-09-15 | 2002-08-28 | Procter & Gamble | Antimicrobial quinolones, their compositions and uses |
| BRPI0413964B8 (pt) | 2003-09-10 | 2021-05-25 | Kyorin Seiyaku Kk | ácido derivado do ácido carboxílico quinolona, sua composição e agente antibacterial |
| US7563805B2 (en) | 2005-05-19 | 2009-07-21 | Daiichi Pharmaceutical Co., Ltd. | Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| EP1930321A4 (en) * | 2005-09-28 | 2011-04-27 | Daiichi Sankyo Co Ltd | PROCESS FOR THE SYNTHESIS OF 5-AZASPIRO [2.4] -HEPTANE TETRASUBSTITUTED DERIVATIVES AND OPTICALLY ACTIVE INTERMEDIATES THEREOF |
| MX2008012488A (es) | 2006-03-28 | 2008-10-10 | Procter & Gamble | Un proceso de acoplamiento para preparar intermedios de quinolona. |
| ES2366150T3 (es) | 2006-03-28 | 2011-10-17 | Warner Chilcott Company, Llc | Malatos de polimorfos de ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinocarboxílico. |
| JP5322927B2 (ja) | 2007-05-24 | 2013-10-23 | 杏林製薬株式会社 | １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体 |
| WO2019215182A1 (en) * | 2018-05-09 | 2019-11-14 | Bayer Animal Health Gmbh | New quinoline derivatives |
| RU2757741C1 (ru) * | 2021-03-01 | 2021-10-21 | Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) | Производное ципрофлоксацина, обладающее антибактериальной активностью в отношении антибиотикоустойчивых штаммов микроорганизмов |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4123536A (en) * | 1977-12-14 | 1978-10-31 | Warner-Lambert Company | Dialkyl ({[3-(alkoxycarbonyl)-1,4-dihydro-4-oxo-8-quinolinyl]amino}methylene)propanedioates |
| DE3705621C2 (de) * | 1986-02-25 | 1997-01-09 | Otsuka Pharma Co Ltd | Heterocyclisch substituierte Chinoloncarbonsäurederivate |
| JPS62215572A (ja) * | 1986-03-17 | 1987-09-22 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体 |
| US5047538A (en) * | 1990-04-12 | 1991-09-10 | Warner-Lambert Company | Quinolinecarboxylic acid antibacterial agents |
-
1991
- 1991-07-19 DE DE4123918A patent/DE4123918A1/de not_active Withdrawn
-
1992
- 1992-06-26 TW TW081105031A patent/TW201309B/zh active
- 1992-07-03 NO NO922639A patent/NO302886B1/no not_active IP Right Cessation
- 1992-07-06 ES ES92111454T patent/ES2097835T3/es not_active Expired - Lifetime
- 1992-07-06 EP EP92111454A patent/EP0523512B1/de not_active Expired - Lifetime
- 1992-07-06 DE DE59207880T patent/DE59207880D1/de not_active Expired - Fee Related
- 1992-07-06 AT AT92111454T patent/ATE147733T1/de not_active IP Right Cessation
- 1992-07-06 DK DK92111454.2T patent/DK0523512T3/da active
- 1992-07-13 CZ CS922191A patent/CZ282037B6/cs not_active IP Right Cessation
- 1992-07-13 SK SK2191-92A patent/SK279221B6/sk unknown
- 1992-07-14 AU AU19663/92A patent/AU658901B2/en not_active Ceased
- 1992-07-14 MX MX9204110A patent/MX9204110A/es not_active IP Right Cessation
- 1992-07-16 CA CA002073993A patent/CA2073993A1/en not_active Abandoned
- 1992-07-16 FI FI923268A patent/FI103043B/sv active IP Right Grant
- 1992-07-16 IL IL102520A patent/IL102520A/xx not_active IP Right Cessation
- 1992-07-17 PL PL92295331A patent/PL171910B1/pl unknown
- 1992-07-17 IE IE922348A patent/IE80557B1/en not_active IP Right Cessation
- 1992-07-17 JP JP21245092A patent/JP3174405B2/ja not_active Expired - Fee Related
- 1992-07-17 ZA ZA925351A patent/ZA925351B/xx unknown
- 1992-07-17 HU HU9202349A patent/HU219910B/hu not_active IP Right Cessation
- 1992-07-17 RU SU925052410A patent/RU2077533C1/ru active
- 1992-07-18 KR KR1019920012826A patent/KR100240608B1/ko not_active IP Right Cessation
-
1997
- 1997-01-16 GR GR970400065T patent/GR3022305T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI103043B1 (sv) | Förfarande för framställning av nya terapeutiskt användbara 8-vinyl- och 8-etynylkinolonkarboxylsyraderivat och mellanprodukter vilka är användbara vid förfarandet | |
| FI95255C (sv) | Förfarande för framställning av nya terapeutiskt användbara merkaptoacetylamidopyrrolo- och -pyridobensazepinderivat | |
| FI903696A0 (sv) | Förfarande för framställning av antibakteriska 5-alkyl-6-fluor-1,4-dihydro-4-oxo-1,8-naftyridin-3-karboxylsyraderivat | |
| FI875413A (sv) | Förfarande för framställning av nya terapeutiskt användbara spiro-substituerade glutarsyraamider | |
| ES8204437A1 (es) | Un procedimiento para la preparacion de acidos 6-b-hidroxialquilpenicilanicos y sus derivados. | |
| PH25459A (en) | Compound useful in the production of quinoline, naphthyridine carboxylic acids useful as antibacterials | |
| FI944164A0 (sv) | Förfarande för framställning av ättikssyra | |
| FI95704B (sv) | Förfarande för framställning av nya terapeutiskt användbara pyridinderivat | |
| FI104075B1 (sv) | Förfarande för framställning av terapeutiskt användbara 2-karboxitienylkarbamoylpyrrolidin-4-ylkarbapenem-3-karboxylsyraderivat | |
| FI875319A0 (sv) | Derivat av bicykliska aminokarboxylsyror, förfarande för deras framställning och vid framställningen användbara mellanprodukter, samt deras användning | |
| FI890723A0 (sv) | Förfarande för framställning av kinolinkarboxylsyraderivat | |
| FI893677A (sv) | Förfarande för framställning av terapeutiskt användbara 6-fluor-3,5-dihydroxikarboxylsyror och deras derivat | |
| ES8802508A1 (es) | Procedimiento para preparar derivados alquenicos. | |
| DE68926148D1 (de) | Solvate von einem Beta-Lactam-Antibiotikum | |
| FI103881B1 (sv) | Förfarande för framställning av terapeutiskt användbara 5-fenylsulfonylamino(karbonyl)-pyridin-2-karboxylsyraestrar | |
| FI893434A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara cykloalkyltiazolderivat | |
| FI895571A0 (sv) | Förfarande för framställning av kinolonkarboxylsyramellanprodukter | |
| ES2081674T3 (es) | Derivados antibacterianos de los acidos 7-(aminometil-oxa-7-aza-biciclo-(3.3.0.)oct-7-il)quinolon- y naftiridon-carboxilico. | |
| FI905912A (sv) | Förfarande för framställning av farmaceutiskt användbara 6-(1-hydroxietyl)-3-(substituerad tio)-7-oxo-1-azabicyklo/3.2.0/hept-2-en-2-karboxylsyraderivat | |
| FI934054A0 (sv) | Förfarande för framställning av mellanprodukter, som är användbara vid framställning av antibakteriella karboxylsyraderivat | |
| NO165839C (no) | Mellomprodukter for fremstilling av 5r,65-6-(1r-1-hydroksyetyl)-2-(1-okso-3-tiolanyltio-2-penem-3-karboksylsyrer ogfremgangsmaate for fremstilling av mellomproduktene. | |
| ATE144257T1 (de) | Tetrahydro-4-phenylimino-3-thiophenessigsäuren | |
| ES2083961T3 (es) | Acidos 3-anilino-2-hidroxicarbonil-4-tiofenoaceticos. | |
| ATE66453T1 (de) | Herstellung von zwischenverbindungen fuer leukotrien-antagonisten. | |
| FI901520A0 (sv) | Förfarande för framställning av terapeutiskt användbara cefemkarboxylsyraestrar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Owner name: BAYER AKTIENGESELLSCHAFT |